Status | Study |
Recruiting |
Study Name: The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Condition: Ichthyosis Autosomal Recessive Congenital Ichthyosis Lamel Date: 2017-01-17 Interventions: Drug: Secukinumab Anti IL-17A |
Enrolling by invitation |
Study Name: Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris Condition: Ichthyosis Vulgaris Date: 2016-11-08 Interventions: Other: Comparing the effect of moisturizers with 5 and 7.5 % carbamide, resp |
Recruiting |
Study Name: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases Condition: Neutral Lipid Storage Disease Date: 2016-08-04 |
Recruiting |
Study Name: A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis Condition: Congenital Ichthyosis Date: 2016-08-03 Interventions: Drug: PAT-001, 0.1% PAT-001 is |
Recruiting |
Study Name: Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M Condition: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) Neutral Lipid Storage Disease With Date: 2016-07-06 Interventions: Dietary Supplement: CNT-02 Each subject will take 2.0g of the investigational product orally 3 times a d |
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition: Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
Recruiting |
Study Name: A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis Condition: Ichthyosis Date: 2015-11-16 Interventions: Other: Observation |
Active, not recruiting |
Study Name: Clinical Trial Using Humira in Netherton Syndrome Condition: Netherton Syndrome Date: 2014-04-02 Interventions: Drug: Adalimumab |
Recruiting |
Study Name: Natural History and Biological Study of Netherton Syndrome Condition: Netherton Syndrome Healthy Date: 2014-03-05 Interventions: Other: Biopsy Other: Blood sample |
Completed |
Study Name: A Phase 3 Clinical Study of KHK 4827 Condition: Psoriasis Vulgaris Psoriatic Arthritis Pustular; Psoriasis Date: 2014-01-30 Interventions: Drug: KHK4827 140mg SC Experim |